If it's momentum you're looking for, a couple more quarters of earnings and dividend declaration will do the trick. Now accumulation phase. Main board listing may also provide stimulus. For now this is not a daytrader stock.

Those of you complain no dividend don't know how to read financials is it? This company ROIC so high of course let them keep the money to expand production la, earn you more on long run. Let's say conservatively they earn next 3 quarter same as this quarter (even though we know production volume is set to increase middle of this year) then you get 10-12 cent EPS. For a stock currently price 38c. If you dont know how to wait then please go buy crypto or go genting play, lose your money there instead. Biggest shareholder of Esc is the boss la, he is just waiting to collect dividend later at the right time, you all cry mother cry father for what. Just shut up, buy low if you have bullet, if no bullet then just prepare for windfall later. If you know anything about glove former business you will know what I'm talking about. Read the RHB report.

You forget to factor in that previous QR was affected by MCO. This QR was operating according to SOPs without any full shutdown. Harta recently got awarded the UK NHS tender, together with some other familiar names. Total £6 billion over two years. Basically if price go down, buy, if go up, hold.

I much prefer this method of fundraising than issuing new equity via private placement (diluting shares amd dividends). Sentral management making the right decision to reward shareholders and push their value up. Although I'm not bullish on the office reit sector as a whole, I think Sentral proves their quality and are a good buy at current price. Should go back above 1 by year end.

EPF showing strong support

Last QR was announced in late July. Naturally, you have to wait around 3 months, so probably late next month. Just click the financials tab on i3 and you can see.

Fantastic discount for this counter. Great defensive stock with 6-7% yield plus upside for recovery

The hierarchy is (generally) as such: used vehicles -> national vehicles -> Japanese/Korean -> Continental -> Luxury. What we find is that a lot of the middle class people who usually buy Japanese are more likely to drop down to national vehicles for cost savings.

Proton is the main competitor to Perodua in the lower segments (Saga vs Bezza, Myvi vs Iriz) but we find that their new Geely-based products like X50 and X70 are more like eating up the upper tier Japanese and Conti sales (e.g. buy X70 instead of CX-5, X1 or CR-V), rather than eating up Perodua sales. So we just compare la, between the Perodua and Proton of similar segment:

Axia vs No competitor (Axia win)
Bezza vs Saga (Even. Bezza more popular for fuel economy & higher tech, Saga cheaper and better handling)
Myvi vs Iriz (this one I don't need to say).
No competitor vs Persona (Persona win)
Exora vs Alza (Exora wins by a bit, but both models are going to be phased out. Aruz much more expensive than both, currently no competitor).

Look at the sales figures you can see Proton good sales is Saga and Persona, by a lot. Perodua on the other hand has high sales for Axia and Myvi, commendable sales for Bezza and Aruz. Ativa occupies a unique segment in the market and it's hard to say how much overall it will contribute, but the sales so far have been good la.

Perodua's order book is full till the end of the year. Their focus is on production now. Any new bookings must come next year liao. Laku or not?

Check out their latest annual report, you'll see they have new customers from China

Promoters here better go promote to the CEO Tho and 10% holder Mr Toe, both just dumped at the high a couple of days ago. You need to persuade them before you waste time do marketing on i3.

The discussion on this i3 page is too weird, too much nonsense. Go on stockb.it, make an account and follow the discussion there for more rational analysis.

Besides just being a signal of confidence and gaining more attention, I think there are some insti investors who specifically can only buy on the main board, and stay away from ACE listings. Not sure, but anyway the bottom line is current and projected earnings.

Conservatively, my own analysis suggest that Esceram's annual EPS will be anywhere from 12 to 15 for FY2022. PE 10 = RM1.20 to RM1.50.

Depends on your needs and investment strategy. This is the 'buy and then close eye' type of counter. Not very volatile, backed up by high NTA, pays you dividends. The next quarter report will be good but subsequent quarter not good due to FMCO, but you can expect a bounce back in Q4 of this year and Q1-2 of next year. Most likely the SST holiday will be extended yet again. Current entry price is reasonable.

Qr meant for tomorrow. The timing of the QR doesn't matter unless you're mainly thinking of momentum trading. This counter is more suited for value investors, and at this price I think is good for adding. Took advantage of the dip to 52 cents today.

Private placement to expedite additional production capacity (new lines, etc.). Careplus already built new lines that will come into play later this year, and also spent money to buy new accommodation for their workers (more secure, save costs). This private placement will fund additional lines to come in 2022 and 2023. The investments is why so far the dividends from Careplus is quite low compared to other gloves. They prefer to reinvest for higher earnings in future rather than give their money away now.

One thing to note is how automotive sales work. If you're in F&B and you close for 2 months, those two months are lost because people will just have to get their food elsewhere. When you open back, they don't come and buy the quantity of food they lost for 2 months. Whereas when it comes to buying vehicles, if you are going to buy a car in 2021/22, it doesn't matter that you can't buy during a certain month. The pent-up demand will come back when the stores re-open.

With that said, it is still important that the economy does well. If people don't have money, they can't buy cars. But overall I do not expect the total sales to be much affected by the intermittent closures. More important is whether production levels stay up and the marques we invest in continue to offer competitive models that the market wants.

A lot also depends on SOP compliance and covid control (look at Topglove troubles now, they have to shut down). Compared to factories in Selangor, those in Perak and Penang seem to be doing comparatively well. Perak maybe because of lower density overall, less community spread. Esceram's Malaysia operations are mostly around Ipoh.

I believe automotive manufacturing isn't open during MCO. Sales won't be running anyhow, but if they could do some manufacturing during this, there would be more stock ready for when things re-open. The wait time for some car models was quite long due to demand

The good news (for investors at least) is that Carepls is not affected by the recent EMCO shutdown of gloves in Selangor. Their operations are in N9 (which I'm sure everyone here knows) and one of their recent capex was in their worker accommodation. As it's newly acquired during COVID season, I hope that they're safer than the poor quality accommodation that some of the other glove-makers are famous for.

I think it's too early to be able to forecast a dividend yield percentage from Esceram just because of a one-off (and very generous) special dividend of 4 cents. Yes historically they do give dividends regularly but these are exceptional times where the company has done a lot of capex to ramp up production, which I prefer because that brings back higher earnings at the end of the day.

For me I'm holding this because of the long term prospects -- Esceram's products are necessary for glove-makers in Malaysia and Thailand, and command a high ASP which I think will not fall at the same rate as glove ASP, due to barriers to entry in the industry. The stakes are high for glove-makers who want to remain competitive, and using the best glove formers is absolutely important for them. The big players are cash rich anyway so they'll throw money at guys like Esceram and Ceramtec. On top of that, Esceram is planning to list on main board and based on my reading, they finally meet the criteria this year. https://www.bursamalaysia.com/listing/get_listed/listing_criteria

Follow the money. Next QR is going to be big

Yeah came in for me too

shareholders of Esceram should be grateful that R & R are gone. If you study the details of the Serba Dinamik issue now, it's hard to escape the conclusion that Karim really cannot be trusted -- likewise his close partners. The projected earnings of Esceram are still strong, and will benefit from the rising volume in the glove industry. Unlike gloves, the ASP won't drop as much because there isn't the same oversupply. The technology to make formers that last long, meet the industry standards and are trusted by glove makers is not easy to develop (Esceram has its own patents and is a longtime player). In this area, only Ceramtec (non-listed company) can be said to be their rivals. So Esceram's position is strong.

Focus on the stock fundamentals, then volatility becomes your friend. I liked this stock at 80c, so just imagine how much i like it at 52.

Why? Spot market prices for glove formers are still up and Esceram's volume and capacity are also up. They are considered essential for the latest FMCO (obviously, if they cannot jalan then glove cannot jalan). And don't forget the Thailand side operations. That's my take la, just do your own DD and decide whether you want to play momentum only or actually invest

What's the story with this new Singaporean subsidiary?

The Board of Directors of D'nonce Technology Bhd ("the Company" or "D'nonce")
is pleased to announce that the Company had on 11 June 2021 incorporated a
wholly-owned subsidiary known as D'nonce Singapore Pte Ltd ("D'nonce
Singapore").

D'nonce Singapore was incorporated in Singapore and will be engaged in
investment holding activities and the provision of management services.

None of the Directors and/or major shareholders and/or persons connected with
a Director or major shareholders of the Company have any interest, direct and
indirect in the said incorporation.

My remisier said will drop to 5sen. Nah i win

Oversold

Once it goes on main board, institutional investors who recognise a good thing can come in. This company has invested a lot into expanding its capacity and will play a crucial role in the glove eco-system for years to come. I've been an owner since 17 cents.

Additional loan moratorium is a big deal for the industry.

@Sincerestock my TP is a bit lower than current prices. Maybe it won't move much due to high institutional holding

This case demonstrates the limitations of charts + sell-on-rumour trading without proper FA. Well, I don't mind getting to buy on discount. At this price, I expect next quarter PE to range from 8-10, maybe better.

Will be watching this counter

There will be a beat down due to the new MCO. I expect good entry prices will come in the next week, maybe (optimistically) even sub 3 ringgit

Let's say the recent quarter EPS is maintained for 3 more quarters (conservative estimate): 1.82*4 = 7.28 EPS, so at current price of 70 cents, PE<10. Considering this is a growth stock and we're expecting higher volume and ASP in the coming year, (spot market for formers), then this stock is going to be way undervalued. Parked at 69.5 to collect more today. Just hold and don't get scared by the operators who are trying to average down.

Take note that the announcement has a bit of time lag. On 21/5 we found out they bought and sold on Wednesday (19/5), contributing to the fluctuation then. Probably on Monday/Tuesday we'll find out that they're the ones who bought to drive the price up before closing on 21/5. I agree it's unprofessional for majority shareholders to behave like this.

Brothers and sisters, hold!

Congratulations holders, and whoever bought on the dip today

Untunglah employee Esceram dapat ESOS, they deserve it for doing the work that the rest of us shareholder profit from. Any dilution effect is minimal, the share issued under ESOS is less than 1%.

@Payyoung Ah I see it now, thank you. Can anyone care to explain why someone would put in a transaction at such high price?

Noob here, where is the source to know the DBT transaction?

I just checked the previous QR: cash or cash equivalents was at RM 58 million as of that quarter, or about 12 sen per share. The 4 sen dividend will pay out about 18-19 million in total

4 sen equals a dividend payout of about RM 18-19 million, more than double of the last quarter's record 10 million PAT. Two factors probably come together: (1) next quarter's profits are massive and (2) the company decided to pay out some of the retained earnings over the year (Esceram is a net cash company after all). Will this mark a shift in policy to be a dividend stock?

Great interview, thanks Terence. Great to hear from the CEO himself.

The fact that Kamal Tan disposed of such huge amounts on Thursday but Friday priced still remain same level tells you a lot. Hold tight!

It's always been 10% deducted bro, maybe you just didn't notice last time

Before Wan Dollah comes in, I prefer to see the taukeh 'Laupan puluh' first

The latest proposal for MBMR to buy back another 10% shares will probably be approved, so this will lead to less shares out in the open market for retailers. They probably want to do it because prices are still quite low at this stage, and more treasury shares means more of the dividends get kept in the company as cash flow. What does it mean for retailers?

1. Less exposure to open market means less volatility, less likely to goreng.
2. Higher treasury shares will incentivise them to continue their dividend policy or even make it more generous.
3. On the short term, the buy-back will trigger a rise in share prices, because of temporary buying pressure. This may raise interest in this counter.
4. It will likely improve the financial ratios of the company. They are basically taking advantage of their current high profits but discounted share price.

Really impressive.

As always, just do your research and look for arbitrage: sound fundamentals + discount + potential earnings growth